Patent Category: Therapies

Inhibitors of interactions between TRF1-TIN2 or TRF2-TIN2 telomeric proteins for use in anticancer therapy

18.09.2025

The present invention relates to a novel compounds for use in treatment or prevention of cancer, in particular to use of said compounds as an inhibitors of interactions between TRF1-TIN2 or TRF2-TIN2 telomeric proteins. Due to the fact that telomerase is reactivated in most cancerous cells it became a promising target for anticancer chemotherapy. However, despite the fact that telomeres of cancerous cells are usually shorter than telomeres of surrounding cells, decreasing of telomere ...

PoliRGD peptides obtained by chemical and biotechnology methods with injury-reducing and/or neuroprotective effects and a kit for their activity evaluation

18.09.2025

The subject of the invention is new peptide derivatives of platelet derived growth factor, for use of these compounds as a therapeutic agent for the regeneration and/or treatment of neurological ...

Compositions and methods for treating glioma

26.08.2025

The present invention is directed to isolated peptides, compositions comprising same and methods of use thereof for treating tumors infiltrated with macrophages, such as ...

Bile acid derivatives and use thereof

20.08.2025

A description of the invention will be available after the patent application is published. Nencki Institute is the sole applicant. For more information contact Technology Transfer Office.

Bile acid for use in the prevention or treatment of inflammatory diseases of the respiratory system

20.08.2025

A description of the invention will be available after the patent application is published. Nencki Institute is the sole applicant. For more information contact Technology Transfer Office.